dysprosium dtpa has been researched along with meglumine in 1 studies
Studies (dysprosium dtpa) | Trials (dysprosium dtpa) | Recent Studies (post-2010) (dysprosium dtpa) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
---|---|---|---|---|---|
26 | 0 | 0 | 4,168 | 413 | 1,399 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aicher, KP; Engelstad, BL; Kucharczyk, J; Moseley, ME; Tzika, AA; White, DL | 1 |
1 other study(ies) available for dysprosium dtpa and meglumine
Article | Year |
---|---|
Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
Topics: Acetazolamide; Animals; Brain; Capillaries; Cats; Cerebrovascular Circulation; Contrast Media; Dextrans; Electron Spin Resonance Spectroscopy; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Image Enhancement; Iron; Iron-Dextran Complex; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Organometallic Compounds; Oxides; Pentetic Acid; Rats; Rats, Inbred Strains; Rheology | 1992 |